Suppression of inducible nitric oxide synthase expression by furfuran lignans from flower buds of Magnolia fargesii in BV-2 microglial cells

Phytotherapy Research

Volumn 24, Issue 5, 2010, Pages 748-753

  Kim, Ji Sun ^a   Kim, Jae Yeon ^a   Lee, Hwa Jin ^a   Lim, Hyo Jin ^a   Lee, Da Yeon ^a   Kim, Do Hee ^a   Ryu, Jae Ha ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

Lignan; Magnolia fargesii; Microglia; Nitric oxide synthase; Peroxynitrite

Indexed keywords

ASCHANTINE; FARGESIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; KOBUSIN; MAGNESIUM CHLORIDE; NITRIC OXIDE; PEROXYNITRITE; SUPEROXIDE;

ANIMAL CELL; ARTICLE; BIOASSAY; BUD; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG STRUCTURE; ENZYME INHIBITION; FLOWER; FRACTIONATION; IC 50; IN VITRO STUDY; MICROGLIA; MOUSE; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; BENZODIOXOLES; CELL LINE; ENZYME INHIBITORS; FLOWERS; FREE RADICAL SCAVENGERS; INHIBITORY CONCENTRATION 50; LIGNANS; MAGNOLIA; MICE; MICROGLIA; MOLECULAR STRUCTURE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II;

MAGNOLIA FARGESII;

EID: 77952065006     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3028     Document Type: Article

References (26)

1. Ahmed AA, Mahmoud AA, Ali ET, Tzakou O, Couladis M, Mabry TJ, Gati T, Toth G. 2002. Two highly oxygenated eudesmanes and 10 lignans from Achillea holosericea. Phytochemistry 59: 851-856. (Pubitemid 34326842)
2. Akagi M, Tada T, Shirono A, Fukuyama Y, Nakade K, Zhai H, Yasui Y, Akagi R. 2004. Neuroprotective effect of magnolol in the hippocampus of senescence-accelerated mice (SAMP1). Int Congress Series 1260: 405-408.
3. Biavatti MW, Vieira PC, da Silva MF, Fernandes JB, Degani AL, Cass QB, Schefer AB, Ferreira AG. 2001. Separation and NMR studies on lignans of Raulinoa echinata. Phytochem Analysis 12: 64-68.
4. Bredt DS, Snyder SH. 1990. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682-685. (Pubitemid 20051434)
5. Chabrier PE, Demerle-Pallardy C, Auguet M. 1999. Nitric oxide synthases: targets for therapeutic strategies in neurological diseases. Cell Mol Life Sci 55: 1029-1035. (Pubitemid 29361069)
6. Choi MS, Lee SH, Cho HS, Kim Y, Yun YP, Jung HY, Jung JK, Lee BC, Pyo HB, Hong JT. 2007. Inhibitory effect of obovatol on nitric oxide production and activation of NF-kappaB/ MAP kinases in lipopolysaccharide-treated RAW 264.7cells. Eur J Pharmacol 556: 181-189.
7. 15N] nitrate in biological fluids. Anal Biochem 126: 131-138.
8. Jin DQ, Lim CS, Hwang JK, Ha I, Han JS. 2005. Anti-oxidant and anti-inflammatory activities of macelignan in murine hippocampal cell line and primary culture of rat microglial cells. Biochem Biophys Res Commun 331: 1264-1269. (Pubitemid 40692493)
9. Jung KY, Kim DS, Oh SR, Park SH, Lee IS, Lee JJ, Shin DH, Lee HK. 1998. Magnone A and B, novel anti-PAF tetrahydrofuran lignans from the flower buds of Magnolia fargesii. J Nat Prod 61: 808-811.
10. Kimura M, Suzuki J, Yamada T, Yoshizaki M, Kikuchi T, Kadota S, Matsuda S. 1985. Anti-inflammatory effect of neolignans newly isolated from the crude drug 'Shin-I' (flos Magnoliae). Planta Med 51: 291-293.
11. Kobayashi S, Kobayashi H, Matsuno H, Kimura I, Kimura M. 1998. Inhibitory effects of anti-rheumatic drugs containing magnosalin, a compound from 'Shin-i' (Flos magnoliae), on the proliferation of synovial cells in rheumatoid arthritis models. Immunopharmacol 39: 139-147.
12. Kooy NW, Royall JA, Ischiropoulos H, Beckman JS. 1994. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic Biol Med 16: 149-156.
13. Lee MM, Huang HM, Hsieh MT, Chen CS, Yeh FT, Kuo JS. 2000. Anti-inflammatory and neuroprotective effects of magnolol in chemical hypoxia in rat cultured cortical cells in hypoglycemic media. Chin J Physiol 43: 61-67.
14. Liou K-T, Lin S-M, Huang S-S, Chih C-L, Tsai S-K. 2003a. Honokiol ameliorates cerebral infarction from ischemia-reperfusion injury in rats. Planta Med 69: 130-134. (Pubitemid 36384496)
15. Liou K-T, Shen Y-C, Chen C-F, Tsao C-M, Tsai S-K. 2003b. The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Eur J Pharmacol 475: 19-27. (Pubitemid 37088002)
16. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. 1992. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA 89: 6711-6715.
17. Matsuda H, Kageura T, Oda M, Morikawa T, Sakamoto Y, Yoshikawa M. 2001. Effects of constituents from the bark of Magnolia obovata on nitric oxide production in lipopolysaccharide-activated macrophages. Chem Pharm Bull 49: 716-720. (Pubitemid 32587118)
18. McGeer PL, McGeer EG. 1995. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21: 195-218.
19. Namba T. 1980. Coloured Illustrations of Wakan-Yaku (Crude Drugs in Japan, China and Neighboring Countries) (Vol. II). Hoikusha Publishing: Osaka.
20. Nonaka M, Chen XH, Pierce JE, Leoni MJ, McIntosh TK, Wolf JA, Smith DH. 1999. Prolonged activation of NF-kappaB following traumatic brain injury in rats. J Neurotrauma 16: 1023-1034.
21. Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, Karjalainen-Lindsberg ML, Weih F, Frank N, Schwaninger M, Koistinaho J. 2004. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 35: 987-991.
22. Petrova TV, Akama KT, Van Eldik LJ. 1999. Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Proc Natl Acad Sci USA 96: 4668-4673.
23. Szabo C. 1996. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 6: 79-88. (Pubitemid 126727744)
24. Tieu K, Ischiropoulos H, Przedborski S. 2003. Nitric oxide and reactive oxygen species in Parkinson's disease. IUBMB Life 55: 329-335. (Pubitemid 36975543)
25. Tse AK, Wan CK, Zhu GY, Shen XL, Cheung HY, Yang M, Fong WF. 2007. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation. Mol Immunol 44: 2647-2658. (Pubitemid 46240318)
26. Youn HS, Lim HJ, Choi YJ, Lee JY, Lee MY, Ryu J-H. 2008. Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists. Int Immunopharmacol 8: 495-501.